Thiostrepton suppresses rhabdomyosarcoma progression by targeting the PI3K–AKT pathway Post author:admin Post published:October 30, 2025 Post category:uncategorized Rhabdomyosarcoma (RMS) accounts for up to 10% of childhood cancers and nearly half of pediatric soft tissue sarcomas. You Might Also Like LncRNA ZNF593-AS offers hope for heart disease treatment August 28, 2024 Neural circuits in flies provide insights into human eating January 30, 2026 First vascularized model of stem cell islet cells May 24, 2025